Wegovy is also approved to reduce the risk of serious cardiovascular events, such as heart attack and stroke, in adults with cardiovascular disease and obesity or overweight
95% CI, 0.20 to 0.32) and recurrent (HR, 0.44
Tumor angiogenesis, the formation of blood vessels that feed malignant growths, is a recognized hallmark of cancer progression, and any compound upregulating VEGF or related angiogenic mediators carries a theoretical association with the process
CKD can affect the metabolism of some nutrients, and supplementation may not be advisable in those with advanced CKD
Building that plan into care from the beginning can prevent weight regain, improve long-term health improvements, and reduce ongoing costs